XENGLU MET XR 12.5/1000MG TAB

Xenglu Met XR 12.5/1000mg is a sustained-release combination tablet designed for comprehensive diabetes management. Each tablet contains 12.5mg of glimepiride and 1000mg of metformin hydrochloride, working synergistically to regulate blood glucose levels. The extended-release formulation ensures prolonged therapeutic effect, reducing dosing frequency for improved patient compliance. Ideal for type 2 diabetes patients requiring dual-agent therapy, this medication helps maintain stable glycemic control throughout the day while minimizing fluctuations.